Publication | Closed Access
Programmed Cell Death Ligand 1 Expression in Canine Cancer.
65
Citations
0
References
2017
Year
Canine tumors with PD-L1 expression that were identified in this study are potential candidates for antiPD-1 and antiPD-L1 therapy.